Cargando…

Chest MRI to diagnose early diaphragmatic weakness in Pompe disease

BACKGROUND: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Harlaar, Laurike, Ciet, Pierluigi, van Tulder, Gijs, Pittaro, Alice, van Kooten, Harmke A., van der Beek, Nadine A. M. E., Brusse, Esther, Wielopolski, Piotr A., de Bruijne, Marleen, van der Ploeg, Ans T., Tiddens, Harm A. W. M., van Doorn, Pieter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789462/
https://www.ncbi.nlm.nih.gov/pubmed/33413525
http://dx.doi.org/10.1186/s13023-020-01627-x
_version_ 1783633244580741120
author Harlaar, Laurike
Ciet, Pierluigi
van Tulder, Gijs
Pittaro, Alice
van Kooten, Harmke A.
van der Beek, Nadine A. M. E.
Brusse, Esther
Wielopolski, Piotr A.
de Bruijne, Marleen
van der Ploeg, Ans T.
Tiddens, Harm A. W. M.
van Doorn, Pieter A.
author_facet Harlaar, Laurike
Ciet, Pierluigi
van Tulder, Gijs
Pittaro, Alice
van Kooten, Harmke A.
van der Beek, Nadine A. M. E.
Brusse, Esther
Wielopolski, Piotr A.
de Bruijne, Marleen
van der Ploeg, Ans T.
Tiddens, Harm A. W. M.
van Doorn, Pieter A.
author_sort Harlaar, Laurike
collection PubMed
description BACKGROUND: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI. METHODS: Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior–posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups. RESULTS: We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position < 80% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position ≥ 80% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (p < 0.001). Anterior–posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (p = 0.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients. CONCLUSIONS: Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm.
format Online
Article
Text
id pubmed-7789462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77894622021-01-07 Chest MRI to diagnose early diaphragmatic weakness in Pompe disease Harlaar, Laurike Ciet, Pierluigi van Tulder, Gijs Pittaro, Alice van Kooten, Harmke A. van der Beek, Nadine A. M. E. Brusse, Esther Wielopolski, Piotr A. de Bruijne, Marleen van der Ploeg, Ans T. Tiddens, Harm A. W. M. van Doorn, Pieter A. Orphanet J Rare Dis Research BACKGROUND: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI. METHODS: Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior–posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups. RESULTS: We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position < 80% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position ≥ 80% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (p < 0.001). Anterior–posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (p = 0.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients. CONCLUSIONS: Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm. BioMed Central 2021-01-07 /pmc/articles/PMC7789462/ /pubmed/33413525 http://dx.doi.org/10.1186/s13023-020-01627-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Harlaar, Laurike
Ciet, Pierluigi
van Tulder, Gijs
Pittaro, Alice
van Kooten, Harmke A.
van der Beek, Nadine A. M. E.
Brusse, Esther
Wielopolski, Piotr A.
de Bruijne, Marleen
van der Ploeg, Ans T.
Tiddens, Harm A. W. M.
van Doorn, Pieter A.
Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title_full Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title_fullStr Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title_full_unstemmed Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title_short Chest MRI to diagnose early diaphragmatic weakness in Pompe disease
title_sort chest mri to diagnose early diaphragmatic weakness in pompe disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789462/
https://www.ncbi.nlm.nih.gov/pubmed/33413525
http://dx.doi.org/10.1186/s13023-020-01627-x
work_keys_str_mv AT harlaarlaurike chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT cietpierluigi chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT vantuldergijs chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT pittaroalice chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT vankootenharmkea chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT vanderbeeknadineame chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT brusseesther chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT wielopolskipiotra chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT debruijnemarleen chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT vanderploeganst chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT tiddensharmawm chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease
AT vandoornpietera chestmritodiagnoseearlydiaphragmaticweaknessinpompedisease